Early serum albumin changes in patients with ulcerative colitis treated with tacrolimus will predict clinical outcome

Table 1 Baseline characteristics of patients

Characteristics	n = 47
Age (yr), mean (range) ± SD	44.9 (16-78) ± 18.7
Male/female, n (%)	38/9 (80.9/10.6)
Disease duration (yr), mean (range) ± SD	3.2 (0.1-42) ± 7.0
Disease extent, n (%)
Extensive colitis	42 (89.4)
Left sided colitis	5 (10.6)
CAI (Rachmilewitz index) mean (range) ± SD	11.0 (7-17) ± 2.7
MES
MES 2	9 (19.1)
MES 3	38 (80.9)
Medication at study, n (%)
Oral 5-ASA	21 (44.7)
Suppository 5-ASA	7 (14.9)
Systemic steroids	28 (59.6)
Immunomodulators	10 (21.3)
Biologics	11 (23.4)
History of biologics, n (%)	12 (25.5)
Time to high trough level (d), mean (range) ± SD	8.1 (0-46) ± 7.5

5-ASA: 5-aminosalicylic acid; CAI: Clinical activity index; MES: Mayo endoscopic subscore.